BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
Anticancer prodrugs
,
Lipitor
,
rs2476601
,
MYC
,
Angiogenesis
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
chylomicron
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Fetal liver
Liver
Fetal lung
Ileum mucosa
Small intestine
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Encephalomyelitis
Encephalitis
Vesicular stomatitis Indiana virus disease
Hyperlipoproteinemia
Acute hepatic failure
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
niguldipine
sitagliptin
OTS-167
CGP 60474
GSK690693
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR20B
il4r
LAT
HSD17B10
FN1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Pancreatic mRNA expression profiles throughout differentiation
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Colorectal cancer liver metastases, primary tumors and prospective response to FOLFIRI chemotherapy
Explore Curated Studies Results
Literature
Most Relevant Literature
Glucagon-like Peptide-2 Acutely Enhances Chylomicron Secretion in Humans Without Mobilizing Cytoplas…
Could the chylomicron marker apoB48 be of value in the diagnosis of chylous effusions?
Intestinal SEC16B modulates obesity by regulating chylomicron metabolism.
Lymphatics - not just a chylomicron conduit.
Biphasic Effect of Curcuminoids on Oxidation of Postprandial Chylomicrons.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of SB CD on Chylomicron
Pilot Study-Quantitative Analysis of Positional Fatty Acids in Postprandial Chylomicron Triacylglyce…
Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterole…
The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de …
Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ